XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
252 hedge funds and large institutions have $6.92B invested in Acceleron Pharma in 2020 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 82 increasing their positions, 85 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4% less repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 85
19% less call options, than puts
Call options by funds: $19.6M | Put options by funds: $24.2M
Holders
252
Holding in Top 10
8
Calls
$19.6M
Puts
$24.2M
Top Buyers
| 1 | +$48.8M | |
| 2 | +$44.8M | |
| 3 | +$42.3M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$38.3M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$25.8M |
Top Sellers
| 1 | -$149M | |
| 2 | -$67.6M | |
| 3 | -$46.2M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$34.7M |
| 5 |
KCM
Kingdon Capital Management
New York
|
-$29.3M |